Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors.
Sánchez-Más. Jesús J; Guillo. Lidia A LA; Zanna. Paola P; Jiménez-Cervantes. Celia C; García-Borrón. José C JC
Key Findings
- MC1R and its mouse version become desensitized after repeated agonist exposure
- GRK2 and GRK6 are the main kinases that cause this desensitization
- GRK6 can also suppress the receptor’s activity even without an agonist
Practical Outcomes
- Repeated or high‑frequency melanotan‑I dosing may lead to reduced tanning response due to receptor desensitization. Using lower, spaced‑out doses or occasional breaks could help maintain effectiveness. No direct dosing protocol is provided, but the findings suggest moderation to avoid rapid desensitization.
Summary
The study shows that the skin‑color receptor (MC1R) becomes less responsive when repeatedly stimulated, and this “turn‑off” is driven by two proteins called GRK2 and GRK6. Blocking GRK2 makes the receptor react more strongly, while GRK6 also lowers the receptor’s baseline activity. These mechanisms could explain why the tanning effects of melanotan‑I may fade with frequent use.
Abstract
The melanocortin 1 receptor, a G protein-coupled receptor positively coupled to adenylyl cyclase, is a key regulator of epidermal melanocyte proliferation and differentiation and a determinant of human skin phototype and skin cancer risk. Despite its potential importance for regulation of pigmentation, no information is available on homologous desensitization of this receptor. We found that the human melanocortin 1 receptor (MC1R) and its mouse ortholog (Mc1r) undergo homologous desensitization in melanoma cells. Desensitization is not dependent on protein kinase A, protein kinase C, calcium mobilization, or MAPKs, but is agonist dose-dependent. Both melanoma cells and normal melanocytes express two members of the G protein-coupled receptor kinase (GRK) family, GRK2 and GRK6. Cotransfection of the receptor and GRK2 or GRK6 genes in heterologous cells demonstrated that GRK2 and GRK6 impair agonist-dependent signaling by MC1R or Mc1r. However, GRK6, but not GRK2, was able to inhibit MC1R agonist-independent constitutive signaling. Expression of a dominant negative GRK2 mutant in melanoma cells increased their cAMP response to agonists. Agonist-stimulated cAMP production decreased in melanoma cells enriched with GRK6 after stable transfection. Therefore, GRK2 and GRK6 seem to be key regulators of melanocortin 1 receptor signaling and may be important determinants of skin pigmentation.
Study Information
pubmed
2005
2005-01-13T00:00:00.000Z
10.1210/me.2004-0227